Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

Acorda Therapeutics initiates second clinical trial of Glial Growth Factor 2 in heart failure patients

LCH hosts international dental teaching symposium at Jessie Trice Community Health Center

LCH hosts international dental teaching symposium at Jessie Trice Community Health Center

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

FDA accepts NDA for MNK-795 oral formulation

FDA accepts NDA for MNK-795 oral formulation

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Orlando Health and UF health partner to expand neurosurgery program

Orlando Health and UF health partner to expand neurosurgery program

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Depomed receives complete response letter for SEFELSA NDA

Depomed receives complete response letter for SEFELSA NDA

Teh Seng’s generic Lidoderm manufacturing facility in Taiwan successfully completes FDA cGMP audit

Teh Seng’s generic Lidoderm manufacturing facility in Taiwan successfully completes FDA cGMP audit

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Convergence starts Phase II proof of concept study with CNV2197944 in pain associated with PHN

Convergence starts Phase II proof of concept study with CNV2197944 in pain associated with PHN

AANS, CNS urge Congress to restore Medicare payments for stereotactic radiosurgery

AANS, CNS urge Congress to restore Medicare payments for stereotactic radiosurgery

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

EpiCept fourth quarter revenue decreases to $0.1 million

EpiCept fourth quarter revenue decreases to $0.1 million

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

HSS involving resiniferatoxin receives U.S. patent to alleviate intractable pain

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

EpiCept third quarter revenue increases to $0.9 million

EpiCept third quarter revenue increases to $0.9 million

EpiCept, Immune Pharmaceuticals enter definitive merger agreement

EpiCept, Immune Pharmaceuticals enter definitive merger agreement

Depomed third quarter 2012 revenue increases to $33.3 million

Depomed third quarter 2012 revenue increases to $33.3 million

Neuros Medical honored as most promising startup

Neuros Medical honored as most promising startup